Chroneme reads how your health changes over time. Every signal, from every provider, across years. And when something is developing, it knows. Before the doctor. Before the diagnosis. Before the emergency. No black box, by design. Intelligence clinicians can question, understand, and trust.
We tested Chroneme across hundreds of thousands of ICU stays from 208 hospitals. It detected deterioration hours to days before standard scoring systems flagged anything. AUROC 0.926, outperforming the best general-purpose AI (0.849) on the same clinical data.
Zohaib Akhtar is the CEO and founder of Chroneme. His background spans medicine, public health, biomedical design, business, and AI systems. Trained at Johns Hopkins Medicine, Bloomberg School of Public Health, Cleveland Clinic, Northwestern Kellogg, and Aarhus University. Also founder of OpenCura.
Chenyu Li, Co-Founder. Adam Wolfe, Co-Founder.
Founded 2025. Chroneme, Inc. 13 patent families filed. Contact: mail@chroneme.com
An AUROC of 0.95 sounds excellent. But if the condition has 5% prevalence, the positive predictive value may be as low as 31%. Most validation studies are conducted at the institution that built the model. Chroneme was validated across 208 hospitals using eICU-CRD and MIMIC-IV, two independent databases with different patient populations.